Merck & Co Inc <MRK.N>: Argus Research raises target price to $145 from $130
MRK•Related News
Nova management to attend Citi Global Technology Conference fireside chat
NVMI•
TurnOnGreen unit Digital Power shifts DUC800-28 military-grade power supply to full-scale production
TOGI•
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
KLRS•
IBM, Together AI sign $240 million multi-year deal to scale open-source AI inference on IBM Cloud
IBM•
Hims & Hers Health Inc <HIMS.N>: Morgan Stanley raises target price to $28.00 from $21.00
HIMS•